| 1.1601 0.02 (1.76%) | 03-18 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |   |
|||
| Targets | 6-month : | 1.55 | 1-year : | 1.74 |
| Resists | First : | 1.32 | Second : | 1.49 |
| Pivot price | 1.16 |
|||
| Supports | First : | 1.07 | Second : | 0.89 |
| MAs | MA(5) : | 1.15 |
MA(20) : | 1.16 |
| MA(100) : | 1.14 |
MA(250) : | 1.24 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 14.8 |
D(3) : | 16.4 |
| RSI | RSI(14): 47.6 |
|||
| 52-week | High : | 2.3 | Low : | 0.81 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ HAO ] has closed above bottom band by 45.7%. Bollinger Bands are 33.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 1.22 - 1.23 | 1.23 - 1.23 |
| Low: | 1.13 - 1.13 | 1.13 - 1.14 |
| Close: | 1.15 - 1.16 | 1.16 - 1.17 |
Haoxi Health Technology Limited, through its subsidiaries, provides online marketing solutions in China. It offers online marketing solutions, including online short video marketing solutions to advertisers through its media partners; and customized marketing solutions by planning, producing, placing, and optimizing online ads to help advertisers acquire, convert, and retain consumers on various online media platforms. The company places its ads through mainstream online short video and social media platforms, such as Toutiao, Douyin, WeChat, and Sina Weibo. It serves advertiser client base primarily in the healthcare industry. The company was founded in 2018 and is based in Beijing, China.
Mon, 16 Mar 2026
Haoxi Health Technology appoints Chuanjie Hu to board following director resignation - Investing.com Nigeria
Fri, 06 Mar 2026
Haoxi Health Technology Names New Independent Director After Board Resignation - TipRanks
Wed, 04 Mar 2026
Haoxi Health, Eaglepoint AI forge strategic partnership - TipRanks
Tue, 03 Mar 2026
HAOXI HEALTH TECHNOLOGY and Eaglepoint AI Forge Strategic Partnership to Enter AI-Powered Health Management Track - Yahoo Finance
Tue, 03 Mar 2026
AI ‘Digital Health Manager’ targets sub-healthy, chronic disease users - Stock Titan
Fri, 23 Jan 2026
Haoxi Health Technology launches $80 million at-the-market share offering - Investing.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Outperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Communication Services
|
|
|
Industry:
Advertising Agencies
|
|
| Shares Out | 59 (M) |
| Shares Float | 3 (M) |
| Held by Insiders | 0.7 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 48 (K) |
| Shares Short P.Month | 70 (K) |
| EPS | 1.32 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 6 |
| Profit Margin | 11.8 % |
| Operating Margin | -21.2 % |
| Return on Assets (ttm) | -6.8 % |
| Return on Equity (ttm) | 27 % |
| Qtrly Rev. Growth | -64.6 % |
| Gross Profit (p.s.) | 0.01 |
| Sales Per Share | 0.55 |
| EBITDA (p.s.) | -0.03 |
| Qtrly Earnings Growth | 172.6 % |
| Operating Cash Flow | -3 (M) |
| Levered Free Cash Flow | -6 (M) |
| PE Ratio | 0.87 |
| PEG Ratio | 0 |
| Price to Book value | 0.19 |
| Price to Sales | 2.07 |
| Price to Cash Flow | -20.29 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|